$49.95
NeoVasc – Sustained-Release Niacin
NeoVasc provides 750 mg of sustained-release niacin per tablet for practitioner-directed nutritional support. Clinical research shows that pharmacologic-dose niacin can favorably influence the lipid profile, including raising HDL cholesterol and lowering LDL cholesterol and triglycerides. The sustained-release format is designed for gradual niacin delivery. (NIH Office of Dietary Supplements, PubMed)
Important: NeoVasc itself has not been shown in these studies to prevent cardiovascular disease, and high-dose sustained-release niacin should be used under healthcare supervision because of potential liver, glucose, and other adverse effects.
